BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 100 filers reported holding BIOSCRIP INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 1,100 | +120.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 500 | +66.7% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 300 | -89.8% | 0.00% | – |
| Q4 2016 | $3,000 | -66.7% | 2,936 | -41.5% | 0.00% | – |
| Q4 2015 | $9,000 | -87.8% | 5,021 | -87.3% | 0.00% | -100.0% |
| Q3 2015 | $74,000 | -86.9% | 39,531 | -74.6% | 0.00% | -87.5% |
| Q2 2015 | $565,000 | +1612.1% | 155,767 | +1971.9% | 0.01% | +700.0% |
| Q1 2015 | $33,000 | +43.5% | 7,518 | +124.8% | 0.00% | – |
| Q3 2014 | $23,000 | -77.5% | 3,344 | -72.6% | 0.00% | -100.0% |
| Q2 2014 | $102,000 | -66.9% | 12,199 | -72.3% | 0.00% | -60.0% |
| Q1 2014 | $308,000 | +25.2% | 44,101 | +32.7% | 0.01% | +25.0% |
| Q4 2013 | $246,000 | +6.5% | 33,244 | +26.3% | 0.00% | 0.0% |
| Q3 2013 | $231,000 | – | 26,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |